Get all your news in one place.
100's of premium titles.
One app.
Start reading
LiveScience
LiveScience
Clarissa Brincat

A cheap arthritis drug shows promise treating RSV in early study

An illustration shows spiky spherical cells against a purple background.

A cheap, widely available painkiller used to treat conditions like arthritis can significantly reduce RSV in the human respiratory tract, an early-stage laboratory study suggests.

Respiratory syncytial virus (RSV) is the number one reason infants end up in the hospital in the U.S., with babies under 6 months old facing the highest risk of severe disease and death from RSV. It's also a serious health risk for adults over 65.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.